VC-backed Jasper Therapeutics adds new VP to team

Jasper Therapeutics, a biotech company focused on hematopoietic cell transplant therapies, has named Dr. Kevin N. Heller as executive vice president of research and development.

12 August 2020•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail